Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites

Clinical trial NCT01852409 · UNKNOWN

Trial details

NCT number: NCT01852409
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Malignant Ascites

Start date: 2013-05-01
Primary completion: 2015-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.